133477-33-5 Usage
Chemical class
Thiazole compounds
A five-membered aromatic ring containing a sulfur and nitrogen atom.
Molecular structure
Derivative of thiazole
Contains a hydroxyphenyl group, which contributes to its potential pharmaceutical applications.
Potential applications
Pharmaceutical industry
Possible use as an anti-cancer agent.
Anti-inflammatory properties.
Synthesis
Building block for other derivatives
Can be used to synthesize other thiazole derivatives with potential biological activities.
Field of interest
Medicinal and pharmaceutical chemistry
2-(4-hydroxyphenyl)thiazole-4-carboxamide has potential applications in this field due to its various properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 133477-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,4,7 and 7 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 133477-33:
(8*1)+(7*3)+(6*3)+(5*4)+(4*7)+(3*7)+(2*3)+(1*3)=125
125 % 10 = 5
So 133477-33-5 is a valid CAS Registry Number.
133477-33-5Relevant academic research and scientific papers
As opioid receptor antagonists or inverse agonists of the novel compounds
-
Paragraph 0220; 0221, (2016/10/08)
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS
-
, (2011/06/19)
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS
-
, (2010/05/13)
A method of treatment using pharmaceutical compositions containing novel antagonists or inverse agonists at opioid receptors for the treatment of binge eating disorder, anorexia nervosa, bulimia nervosa, excess drug or alcohol use, or eating disorder not otherwise specified.
